Ads
related to: aimovig launch- Dosing & Administration
Learn More About Dosing & Efficacy
On The Healthcare Provider Site.
- MDs: Support Your Patient
Discover Coverage Options & Provide
Your Patients With Access & Support
- HER-MES Clinical Data
Review Safety And Efficacy Info
for Aimovig® On The Official Site.
- Practitioner Resources
Explore Physician Resources To Help
Patients Start & Stay On Aimovig®
- Dosing & Administration
Search results
Amgen Tumbles After Scrapping A $900 Million Prostate Cancer Drug
Investor's Business Daily· 7 months agoAmgen handily beat Wall Street's earnings forecasts Tuesday, but Amgen stock tumbled after the...
Why Is Amgen (AMGN) Down 4.2% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 year agoIt has been about a month since the last earnings report for Amgen (AMGN). Shares have lost about...
Amgen (AMGN) Q2 Earnings Beat Estimates, 2023 View Raised
Zacks via Yahoo Finance· 10 months agoAmgen AMGN reported second-quarter 2023 earnings of $5.00 per share, which beat the Zacks Consensus...
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Zacks via Yahoo Finance· 2 years agoIt doesn't matter your age or experience: taking full advantage of the stock market and investing...
Amgen (AMGN) Beats Q2 Earnings Estimates, to Buy Chemocentryx
Zacks via Yahoo Finance· 2 years agoAmgen AMGN reported second-quarter 2022 earnings of $4.65 per share, which beat the Zacks Consensus...
Amgen Inc. (NASDAQ:AMGN) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoAmgen Inc. (NASDAQ:AMGN) Q4 2022 Earnings Call Transcript January 31, 2023 Amgen Inc. misses on...
Amgen 1st quarter profit falls as costs rise, sales up 2%
Reuters via Yahoo Finance· 1 year ago(Reuters) -Amgen Inc on Thursday reported lower first-quarter profit as expenses rose and a 2%...
Amgen (AMGN) Valuation: A Comprehensive Analysis of Its Market Value
GuruFocus.com via Yahoo Finance· 8 months agoAs of October 10, 2023, Amgen Inc (NASDAQ:AMGN) experienced a day's loss of -1.02%, with a 3-month...
Ads
related to: aimovig launch